Active Ingredient(s): Ursodeoxycholic Acid, Ursodiol
FDA Approved: * December 31, 1987
Pharm Company: * WATSON PHARMS
Category: Gallstones

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Actigall Overview

Ursodeoxycholic acid (UDCA), also known as ursodiol, is a secondary bile acid, produced in humans and most other species from metabolism by intestinal bacteria. It is synthesized in the liver in some species, and was first identified in bear bile, which is the derivation of its name Ursus. In purified form, it has been used to treat or prevent several diseases of the liver or bile ducts. It is available as a generic medication.[5][6] Contents 1 Medical uses...

Read more Actigall Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Actigall Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ursodeoxycholic Acid, Ursodiol
  • Capsule: 150mg, 300mg
  • Tablet: 250mg, 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Actigall: (2 results)

Sorted by National Drug Code
  • 0023-6145 Actigall 300 mg Oral Capsule by Allergan, Inc.
  • 52544-930 Actigall 300 mg Oral Capsule by Watson Pharma, Inc.

Other drugs which contain Ursodeoxycholic Acid, Ursodiol or a similar ingredient: (2 results)